199 related articles for article (PubMed ID: 12463314)
1. Surfactant improves oxygenation in infants and children with pneumonia and acute respiratory distress syndrome.
Herting E; Möller O; Schiffmann JH; Robertson B
Acta Paediatr; 2002; 91(11):1174-8. PubMed ID: 12463314
[TBL] [Abstract][Full Text] [Related]
2. Surfactant treatment for acute respiratory distress syndrome.
López-Herce J; de Lucas N; Carrillo A; Bustinza A; Moral R
Arch Dis Child; 1999 Mar; 80(3):248-52. PubMed ID: 10325705
[TBL] [Abstract][Full Text] [Related]
3. A shared protocol for porcine surfactant use in pediatric acute respiratory distress syndrome: a feasibility study.
Wolfler A; Piastra M; Amigoni A; Santuz P; Gitto E; Rossetti E; Tinelli C; Montani C; Savron F; Pizzi S; D'amato L; Mondardini MC; Conti G; De Silvestri A
BMC Pediatr; 2019 Jun; 19(1):203. PubMed ID: 31215483
[TBL] [Abstract][Full Text] [Related]
4. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial.
Willson DF; Thomas NJ; Markovitz BP; Bauman LA; DiCarlo JV; Pon S; Jacobs BR; Jefferson LS; Conaway MR; Egan EA;
JAMA; 2005 Jan; 293(4):470-6. PubMed ID: 15671432
[TBL] [Abstract][Full Text] [Related]
5. Surfactant therapy improves pulmonary function in infants with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.
Creery WD; Hashmi A; Hutchison JS; Singh RN
Pediatr Pulmonol; 1997 Nov; 24(5):370-3. PubMed ID: 9407571
[TBL] [Abstract][Full Text] [Related]
6. A simplified surfactant dosing procedure in respiratory distress syndrome: the "side-hole" randomized study. Spanish Surfactant Collaborative Group.
Valls-i-Soler A; López-Heredia J; Fernández-Ruanova MB; Gastiasoro E
Acta Paediatr; 1997 Jul; 86(7):747-51. PubMed ID: 9240884
[TBL] [Abstract][Full Text] [Related]
7. Bovine surfactant in the treatment of pneumonia-induced-neonatal acute respiratory distress syndrome (NARDS) in neonates beyond 34 weeks of gestation: a multicentre, randomized, assessor-blinded, placebo-controlled trial.
Rong Z; Mo L; Pan R; Zhu X; Cheng H; Li M; Yan L; Lang Y; Zhu X; Chen L; Xia S; Han J; Chang L
Eur J Pediatr; 2021 Apr; 180(4):1107-1115. PubMed ID: 33084980
[TBL] [Abstract][Full Text] [Related]
8. Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome.
Dinger J; Töpfer A; Schaller P; Schwarze R
Eur J Pediatr; 2002 Sep; 161(9):485-90. PubMed ID: 12200607
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery.
Cai J; Su Z; Zhou Y; Shi Z; Xu Z; Liu J; Xu Z; Yang Y
Eur J Cardiothorac Surg; 2011 Sep; 40(3):557-62. PubMed ID: 21371901
[TBL] [Abstract][Full Text] [Related]
10. Surfactant treatment before first breath for respiratory distress syndrome in preterm lambs: comparison of a peptide-containing synthetic lung surfactant with porcine-derived surfactant.
van Zyl JM; Smith J
Drug Des Devel Ther; 2013; 7():905-16. PubMed ID: 24039400
[TBL] [Abstract][Full Text] [Related]
11. Successful surfactant replacement therapy in two infants with ARDS due to chlamydial pneumonia.
Harms K; Herting E
Respiration; 1994; 61(6):348-52. PubMed ID: 7824816
[TBL] [Abstract][Full Text] [Related]
12. Surfactant replacement in adults and children with ARDS--an effective therapy?
Sinski A; Corbo J
Crit Care Nurse; 1994 Dec; 14(6):54-9. PubMed ID: 7712801
[No Abstract] [Full Text] [Related]
13. [Value of surfactant in the treatment of acute respiratory distress syndrome in a child].
Fraisse A; Paut O; Silicani MA; Viard L; Camboulives J
Arch Pediatr; 1996 Sep; 3(9):891-5. PubMed ID: 8949353
[TBL] [Abstract][Full Text] [Related]
14. Surfactant replacement therapy in acute respiratory distress syndrome from viral pneumonia.
Putz G; Hörmann C; Koller W; Schön G
Intensive Care Med; 1996 Jun; 22(6):588-90. PubMed ID: 8814477
[TBL] [Abstract][Full Text] [Related]
15. Natural surfactant supplementation in ARDS in paediatric age.
Marraro GA; Luchetti M; Galassini EM; Abbiati G
Minerva Anestesiol; 1999 May; 65(5 Suppl 1):92-7. PubMed ID: 10389435
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of severe respiratory distress syndrome with surfactant].
Jacobsen T; Verder H; Skov L; Greisen GO; Friis-Hansen B
Ugeskr Laeger; 1992 Jun; 154(23):1642-5. PubMed ID: 1631999
[TBL] [Abstract][Full Text] [Related]
17. Surfactant therapy in infants and children: three years experience in a pediatric intensive care unit.
Hermon MM; Golej J; Burda G; Boigner H; Stoll E; Vergesslich K; Strohmaier W; Pollak A; Trittenwein G
Shock; 2002 Apr; 17(4):247-51. PubMed ID: 11954821
[TBL] [Abstract][Full Text] [Related]
18. Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
Stenson BJ; Glover RM; Parry GJ; Wilkie RA; Laing IA; Tarnow-Mordi WO
Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F19-24. PubMed ID: 8117122
[TBL] [Abstract][Full Text] [Related]
19. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
Wiseman LR; Bryson HM
Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760
[TBL] [Abstract][Full Text] [Related]
20. Cerebral and lung effects of a new generation synthetic surfactant with SP-B and SP-C analogs in preterm lambs.
Rey-Santano C; Mielgo VE; Murgia X; Gomez-Solaetxe MA; Salomone F; Bianco F; Pelizzi N; Loureiro B; López de Heredia Y Goya J
Pediatr Pulmonol; 2017 Jul; 52(7):929-938. PubMed ID: 28221717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
